Literature DB >> 26541084

The emerging epitranscriptomics of long noncoding RNAs.

Andrew Shafik1, Ulrike Schumann2, Maurits Evers3, Tennille Sibbritt4, Thomas Preiss5.   

Abstract

The pervasive transcription of genomes into long noncoding RNAs has been amply demonstrated in recent years and garnered much attention. Similarly, emerging 'epitranscriptomics' research has shown that chemically modified nucleosides, thought to be largely the domain of tRNAs and other infrastructural RNAs, are far more widespread and can exert unexpected influence on RNA utilization. Both areas are characterized by the often-ephemeral nature of the subject matter in that few individual examples have been fully assessed for their molecular or cellular function, and effects might often be subtle and cumulative. Here we review available information at the intersection of these two exciting areas of biology, by focusing on four RNA modifications that have been mapped transcriptome-wide: 5-methylcytidine, N6-methyladenosine, pseudouridine as well as adenosine to inosine (A-to-I) editing, and their incidence and function in long noncoding RNAs. This article is part of a Special Issue entitled: Clues to long noncoding RNA taxonomy, edited by Dr. Tetsuro Hirose and Dr. Shinichi Nakagawa.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-Methylcytidine; Editing; N6-methyladenosine; Pseudouridine; lncRNA; miRNAs

Mesh:

Substances:

Year:  2015        PMID: 26541084     DOI: 10.1016/j.bbagrm.2015.10.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  34 in total

Review 1.  Pseudouridine as a novel biomarker in prostate cancer.

Authors:  Jennifer A Stockert; Rachel Weil; Kamlesh K Yadav; Natasha Kyprianou; Ashutosh K Tewari
Journal:  Urol Oncol       Date:  2020-07-22       Impact factor: 3.498

2.  Emerging Chemistry Strategies for Engineering Native Chromatin.

Authors:  Yael David; Tom W Muir
Journal:  J Am Chem Soc       Date:  2017-06-27       Impact factor: 15.419

3.  LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis.

Authors:  Kun-Peng Zhu; Xiao-Long Ma; Chun-Lin Zhang
Journal:  Mol Ther       Date:  2017-07-05       Impact factor: 11.454

Review 4.  Experience-dependent neural plasticity, learning, and memory in the era of epitranscriptomics.

Authors:  L J Leighton; K Ke; E L Zajaczkowski; J Edmunds; R C Spitale; T W Bredy
Journal:  Genes Brain Behav       Date:  2017-10-20       Impact factor: 3.449

Review 5.  The Epitranscriptome of Noncoding RNAs in Cancer.

Authors:  Manel Esteller; Pier Paolo Pandolfi
Journal:  Cancer Discov       Date:  2017-03-20       Impact factor: 39.397

Review 6.  Epitranscriptome sequencing technologies: decoding RNA modifications.

Authors:  Xiaoyu Li; Xushen Xiong; Chengqi Yi
Journal:  Nat Methods       Date:  2016-12-29       Impact factor: 28.547

7.  Positive-sense RNA viruses reveal the complexity and dynamics of the cellular and viral epitranscriptomes during infection.

Authors:  Will McIntyre; Rachel Netzband; Gaston Bonenfant; Jason M Biegel; Clare Miller; Gabriele Fuchs; Eric Henderson; Manoj Arra; Mario Canki; Daniele Fabris; Cara T Pager
Journal:  Nucleic Acids Res       Date:  2018-06-20       Impact factor: 16.971

8.  Enterotoxigenic Escherichia coli infection promotes enteric defensin expression via FOXO6-METTL3-m6A-GPR161 signalling axis.

Authors:  Xin Zong; Hong Wang; Xiao Xiao; Yu Zhang; Yuhan Hu; Fengqin Wang; Yizhen Wang; Zeqing Lu
Journal:  RNA Biol       Date:  2020-09-23       Impact factor: 4.652

9.  Noncoding RNA Ginir functions as an oncogene by associating with centrosomal proteins.

Authors:  Suchismita Panda; Meenakshi Setia; Navjot Kaur; Varsha Shepal; Vivek Arora; Divya Kumari Singh; Abir Mondal; Abhishek Teli; Madhura Tathode; Rajendra Gajula; L C Padhy; Anjali Shiras
Journal:  PLoS Biol       Date:  2018-10-08       Impact factor: 8.029

Review 10.  RNA modifications: what have we learned and where are we headed?

Authors:  Michaela Frye; Samie R Jaffrey; Tao Pan; Gideon Rechavi; Tsutomu Suzuki
Journal:  Nat Rev Genet       Date:  2016-05-03       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.